down arrow

Tibet Rhodiola Pharmaceutical Holding Co.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000ZW7
CNY
41.70
3.92 (10.38%)

Dec 05

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Tibet Rhodiola Pharmaceutical Holding Co.
Why is Tibet Rhodiola Pharmaceutical Holding Co. ?
1
  • INTEREST(Q) At CNY 1.99 MM has Grown at inf%
  • DEBTORS TURNOVER RATIO(HY) Lowest at 2.83%
2
With ROE of 24.43%, it has a very attractive valuation with a 3.68 Price to Book Value
  • Over the past year, while the stock has generated a return of 12.10%, its profits have fallen by -3%
  • At the current price, the company has a high dividend yield of 3.8
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Tibet Rhodiola Pharmaceutical Holding Co. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Tibet Rhodiola Pharmaceutical Holding Co. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Tibet Rhodiola Pharmaceutical Holding Co.
-100.0%
0.45
36.36%
China Shanghai Composite
15.19%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
17.51%
EBIT Growth (5y)
20.35%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.64
Sales to Capital Employed (avg)
0.68
Tax Ratio
8.47%
Dividend Payout Ratio
60.00%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
38.04%
ROE (avg)
17.58%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
3.68
EV to EBIT
14.29
EV to EBITDA
13.47
EV to Capital Employed
7.10
EV to Sales
4.62
PEG Ratio
NA
Dividend Yield
3.81%
ROCE (Latest)
49.70%
ROE (Latest)
24.43%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
RAW MATERIAL COST(Y)

Fallen by 1.95% (YoY

CASH AND EQV(HY)

Highest at CNY 6,153.26 MM

NET SALES(Q)

Highest at CNY 923.85 MM

OPERATING PROFIT(Q)

Highest at CNY 333.7 MM

-3What is not working for the Company
INTEREST(Q)

At CNY 1.99 MM has Grown at inf%

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.83%

Here's what is working for Tibet Rhodiola Pharmaceutical Holding Co.
Net Sales
At CNY 923.85 MM has Grown at 33.05%
over average net sales of the previous four periods of CNY 694.34 MM
MOJO Watch
Near term sales trend is very positive

Net Sales (CNY MM)

Net Sales
Highest at CNY 923.85 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit
Highest at CNY 333.7 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Cash and Eqv
Highest at CNY 6,153.26 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost
Fallen by 1.95% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
At CNY 18.44 MM has Grown at inf%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (CNY MM)

Here's what is not working for Tibet Rhodiola Pharmaceutical Holding Co.
Interest
At CNY 1.99 MM has Grown at inf%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debtors Turnover Ratio
Lowest at 2.83%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."